Macular edema formation and deterioration of retinal function after intravitreal bevacizumab injection for XXXX .

@entity1 @entity32 @entity6 @entity1103 @entity1829
PURPOSE: To report a case of @entity6 ( @entity6 ) showing transient @entity1103 ( @entity1103 ) and deteriorated retinal function after intravitreal bevacizumab injection (IVB). METHODS AND RESULTS: A 53-year-old @entity1 received IVB (1.25 mg/0.05 ml) in both eyes for the treatment of @entity6 . There was no treatment-related complication. However, he complained of photopsia in both eyes 6 h after the injection. Slit-lamp examination revealed mild cellular infiltrations (1+) in the anterior chamber in both eyes. Optical coherence tomography showed @entity1103 formation in the left eye. Both full-field and multifocal electroretinography (ERG) revealed the deterioration of all parameters in both eyes compared with pretreatment. The @entity32 in the anterior segment and @entity1103 disappeared 1 day after the injection. ERG parameters were improved 9 days after the injection, except for the N1 and P1 amplitude of multifocal ERG in the left eye. CONCLUSION: We propose that @entity1 who undergo IVB should be carefully informed and followed up for possible complications including @entity1829 .
